雜志介紹

Current Pharmaceutical Design雜志介紹

《Current Pharmaceutical Design》是一本以English為主的未開放獲取國際優秀期刊，中文名稱當前的藥物設計，本刊主要出版、報道醫學-PHARMACOLOGY & PHARMACY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.6，最新CiteScore 指數為6.3。

本刊近期中國學者發表的論文主要有：

• Use of Novel m6A Regulator-mediated Methylation Modification Patterns in Distinct Tumor Microenvironment Profiles to Identify and Predict Glioma Prognosis and Progression, T-cell Dysfunction, and Clinical Response to ICI Immunotherapy

  Author: Zhao, Binghao; Xiang, Zhongtian; Wu, Bo; Zhang, Xiang; Feng, Nan; Wei, Yiping; Zhang, Wenxiong

• Exploration and Practice of Medicine Pathway for Perioperative VTE Prophylactic Anticoagulant Treatment

  Author: Zhang, Bin; Zhang, Chuanzhou; Li, Yongxin; Zhou, Changkai; Shi, Shiqiang; Ji, Hongyan; Li, Jing

• Scutellarin Suppressed Proliferation and Induced Apoptosis in Gastric Cancer via Wnt/beta-catenin Signaling Pathway

  Author: Wang, Zhenkai; Liu, Xiang; Chen, Wanzhen; Guo, Xiujun; Chen, Lili; Wei, Zhiqin; Liu, Dan; Liu, Zheng

• Network Pharmacology and Integrated Molecular Docking Study on the Mechanism of the Therapeutic Effect of Fangfeng Decoction in Osteoarthritis

  Author: Wang, Wenqiao; Li, Min; Si, Hongzong; Jiang, Zehui

英文介紹

Current Pharmaceutical Design雜志英文介紹

Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.